Adv Solid Malig - H&N SCC, ATM Pro / Def NSCLC, Gastric, Breast and Ovarian Cancer
1 clinical trials · Condition
◉ Watch Adv Solid Malig - H&N SCC, ATM Pro / Def NSCLC, Gastric, Breast and Ovarian Cancer
| Record | Firm | Date |
|---|---|---|
| Ascending Doses of Ceralasertib in Combination With Chemotherapy and/or Novel Anti Cancer Agents (NCT02264678) | AstraZeneca | 2014-10-31 |
Track Adv Solid Malig - H&N SCC, ATM Pro / Def NSCLC, Gastric, Breast and Ovarian Cancer automatically
Every clearance here is in the API, with alerts when new ones post.